OptiVol for Precision Medical Management of Heart Failure

NATerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

November 1, 2022

Study Completion Date

November 20, 2022

Conditions
Ischemic and Non-ischemic Cardiomyopathy
Interventions
DEVICE

Medtronic ICD with Opti Vol-Monitor

Physiologic and functional data from Cardiac Implantable Electronic Devices (CIEDs), including information on heart rate, activity, and fluid status derived from the OptiVol monitor, together with a concurrent patient engagement strategy through remote interactions, can be used to optimize the medical management of HF patients implanted with an ICD.

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

University of Rochester

OTHER